Acquisitions (Tables)

12 Months Ended

Sep. 30, 2016

The fair value of consideration transferred was $12.538 billion and consisted of the components below.



(Millions of dollars)
Cash consideration	$	10,085
Noncash consideration-fair value of shares issued	2,269
Noncash consideration-fair value of stock options and other equity awards	184
Total consideration transferred	$	12,538

Fair Value of Company's Ordinary Shares Issued

The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions):



(Millions of dollars)
Total CareFusion shares outstanding	205.3
Conversion factor	0.0777
Number of the Company’s shares issued	15.9
Closing price of the Company’s stock on March 16, 2015	$	142.29
Fair value of the Company’s issued shares	$	2,269

Fair Value of Assets and Liabilities Assumed

All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment.



(Millions of dollars)
Cash and equivalents	$	1,903
Trade receivables, net	526
Inventories	818
Net investment in sales-type leases	1,206
Property, plant and equipment	497
Customer relationships	3,360
Developed technology	2,510
Trademarks	380
Other intangible assets	185
Other assets	278
Total identifiable assets acquired	11,663

Long-term debt	(2,181		)
Deferred tax liabilities	(1,888		)
Other liabilities	(1,306		)
Total liabilities assumed	(5,374		)

Net identifiable assets acquired	6,289

Goodwill	6,249

Net assets acquired	$	12,538

Summary of Pro Forma Results

The following table provides the pro forma results for the years ended September 30, 2016, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.



(Millions of dollars, except per share data)
	2016		2015		2014

Revenues	$	12,497	$	12,368	$	12,288

Net Income	$	1,453	$	1,276	$	1,191

Diluted Earnings per Share	$	6.68	$	5.92	$	5.55